Cargando…
Label-Free Saliva Test for Rapid Detection of Coronavirus Using Nanosensor-Enabled SERS
The recent COVID-19 pandemic has highlighted the inadequacies of existing diagnostic techniques and the need for rapid and accurate diagnostic systems. Although molecular tests such as RT-PCR are the gold standard, they cannot be employed as point-of-care testing systems. Hence, a rapid, noninvasive...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045265/ https://www.ncbi.nlm.nih.gov/pubmed/36978782 http://dx.doi.org/10.3390/bioengineering10030391 |
_version_ | 1784913559906418688 |
---|---|
author | Ganesh, Swarna Dhinakaran, Ashok Kumar Premnath, Priyatha Venkatakrishnan, Krishnan Tan, Bo |
author_facet | Ganesh, Swarna Dhinakaran, Ashok Kumar Premnath, Priyatha Venkatakrishnan, Krishnan Tan, Bo |
author_sort | Ganesh, Swarna |
collection | PubMed |
description | The recent COVID-19 pandemic has highlighted the inadequacies of existing diagnostic techniques and the need for rapid and accurate diagnostic systems. Although molecular tests such as RT-PCR are the gold standard, they cannot be employed as point-of-care testing systems. Hence, a rapid, noninvasive diagnostic technique such as Surface-enhanced Raman scattering (SERS) is a promising analytical technique for rapid molecular or viral diagnosis. Here, we have designed a SERS- based test to rapidly diagnose SARS-CoV-2 from saliva. Physical methods synthesized the nanostructured sensor. It significantly increased the detection specificity and sensitivity by ~ten copies/mL of viral RNA (~femtomolar concentration of nucleic acids). Our technique combines the multiplexing capability of SERS with the sensitivity of novel nanostructures to detect whole virus particles and infection-associated antibodies. We have demonstrated the feasibility of the test with saliva samples from individuals who tested positive for SARS-CoV-2 with a specificity of 95%. The SERS—based test provides a promising breakthrough in detecting potential mutations that may come up with time while also preparing the world to deal with other pandemics in the future with rapid response and very accurate results. |
format | Online Article Text |
id | pubmed-10045265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100452652023-03-29 Label-Free Saliva Test for Rapid Detection of Coronavirus Using Nanosensor-Enabled SERS Ganesh, Swarna Dhinakaran, Ashok Kumar Premnath, Priyatha Venkatakrishnan, Krishnan Tan, Bo Bioengineering (Basel) Article The recent COVID-19 pandemic has highlighted the inadequacies of existing diagnostic techniques and the need for rapid and accurate diagnostic systems. Although molecular tests such as RT-PCR are the gold standard, they cannot be employed as point-of-care testing systems. Hence, a rapid, noninvasive diagnostic technique such as Surface-enhanced Raman scattering (SERS) is a promising analytical technique for rapid molecular or viral diagnosis. Here, we have designed a SERS- based test to rapidly diagnose SARS-CoV-2 from saliva. Physical methods synthesized the nanostructured sensor. It significantly increased the detection specificity and sensitivity by ~ten copies/mL of viral RNA (~femtomolar concentration of nucleic acids). Our technique combines the multiplexing capability of SERS with the sensitivity of novel nanostructures to detect whole virus particles and infection-associated antibodies. We have demonstrated the feasibility of the test with saliva samples from individuals who tested positive for SARS-CoV-2 with a specificity of 95%. The SERS—based test provides a promising breakthrough in detecting potential mutations that may come up with time while also preparing the world to deal with other pandemics in the future with rapid response and very accurate results. MDPI 2023-03-22 /pmc/articles/PMC10045265/ /pubmed/36978782 http://dx.doi.org/10.3390/bioengineering10030391 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ganesh, Swarna Dhinakaran, Ashok Kumar Premnath, Priyatha Venkatakrishnan, Krishnan Tan, Bo Label-Free Saliva Test for Rapid Detection of Coronavirus Using Nanosensor-Enabled SERS |
title | Label-Free Saliva Test for Rapid Detection of Coronavirus Using Nanosensor-Enabled SERS |
title_full | Label-Free Saliva Test for Rapid Detection of Coronavirus Using Nanosensor-Enabled SERS |
title_fullStr | Label-Free Saliva Test for Rapid Detection of Coronavirus Using Nanosensor-Enabled SERS |
title_full_unstemmed | Label-Free Saliva Test for Rapid Detection of Coronavirus Using Nanosensor-Enabled SERS |
title_short | Label-Free Saliva Test for Rapid Detection of Coronavirus Using Nanosensor-Enabled SERS |
title_sort | label-free saliva test for rapid detection of coronavirus using nanosensor-enabled sers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045265/ https://www.ncbi.nlm.nih.gov/pubmed/36978782 http://dx.doi.org/10.3390/bioengineering10030391 |
work_keys_str_mv | AT ganeshswarna labelfreesalivatestforrapiddetectionofcoronavirususingnanosensorenabledsers AT dhinakaranashokkumar labelfreesalivatestforrapiddetectionofcoronavirususingnanosensorenabledsers AT premnathpriyatha labelfreesalivatestforrapiddetectionofcoronavirususingnanosensorenabledsers AT venkatakrishnankrishnan labelfreesalivatestforrapiddetectionofcoronavirususingnanosensorenabledsers AT tanbo labelfreesalivatestforrapiddetectionofcoronavirususingnanosensorenabledsers |